Cite

    Kjølbæk, L. et al. (2020). Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial. Clinical nutrition. 39 (1), pp. 67-79. [Online].